Related Experiment Video
Updated: Sep 19, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Mycobacterium tuberculosis, Streptococcus pneumoniae, and Staphylococcus aureus Co-infection in a Two-Year-Old
Giorgie Petković1, Ivana Maloča Vuljanko1, Zrinka Kačić Miličić1
1Department of Pulmology, Children's Hospital Srebrnjak, Zagreb, HRV.
Abstract:
Co-infections in pulmonary tuberculosis are rare among immunocompetent children in settings with low tuberculosis prevalence. We present a case of a two-year-old immunocompetent child with necrotic pleuropneumonia caused by Mycobacterium tuberculosis, Streptococcus pneumoniae, and Staphylococcus aureus co-infection in a low tuberculosis prevalence setting. A 24-month-old boy presented with a five-day history of cough, followed by three days of high fever and dyspnea. Initial laboratory inflammatory markers were elevated. Chest ultrasound, radiography, and CT scan revealed necrotic changes in the right upper lobe with bullae, pleural effusion, and subcutaneous emphysema. Initial therapeutic procedures included the evacuation of 140 mL of hemorrhagic content from the pleural space. Microbiological analysis revealed Streptococcus pneumoniae type 3 from pleural effusion and Staphylococcus aureus from blood culture. Antimicrobial therapy included ceftriaxone and clindamycin for six weeks. Following flexible bronchoscopy, microbiological culture from aspirated material detected Mycobacterium tuberculosis. Anamnesis did not clarify any prior contact with a tuberculosis-infected individual. This case represents an example of Streptococcus and Staphylococcus superinfection on evolving pulmonary tuberculosis. To our knowledge, no literature is currently available indicating the co-existence of tuberculosis, streptococcal, and staphylococcal pulmonary infection in an immunocompetent patient in a population with low tuberculosis prevalence.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia II: Pathophysiology